BIB

ProShares$86.10+1.00 (+1.18%)
AUM $76.8MER 1.19%NAV $82.55Holdings 274

Price Chart

Key Statistics

Previous Close

$85.10

Day Range

$83.91$86.10

52-Week Range

$39.84$89.34

Avg Volume

13.9K

Dividend Yield

0.75%

Expense Ratio

1.19%

AUM

$76.8M

Shares Outstanding

930.0K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States57.76%
Other34.37%
United Kingdom1.49%
Netherlands1.47%
Ireland1.08%
France0.94%
Denmark0.84%
Germany0.60%
Canada0.54%
Switzerland0.29%
Bermuda0.14%
Jersey0.10%
Singapore0.07%
Iceland0.06%
Cayman Islands0.05%
Spain0.05%
China0.04%
Australia0.04%
Israel0.03%
Belgium0.02%
Taiwan (Province of China)0.01%

Fund Information

Issuer
ProShares
Category
Healthcare
Inception Date
Apr 7, 2010
Exchange
NASDAQ
Description
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

Similar ETFs

SymbolNameAUM
IWMiShares Russell 2000 ETF$78.70B
XLVState Street Health Care Select Sector SPDR ETF$37.29B
VHTVanguard Health Care ETF$18.60B
VTWOVanguard Russell 2000 ETF$14.50B
IWOiShares Russell 2000 Growth ETF$14.28B

The ProShares - Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund issued by ProShares that launched on Apr 7, 2010. It currently manages $76.8M in assets under management. The fund charges an expense ratio of 1.19%. The fund holds 274 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 60.3% of the fund

RankSymbolNameWeight %SharesMarket Value
1Net Other Assets (Liabilities)34.19%26,261,986$26.3M
2GILDGILEAD SCIENCES INC4.86%28,121$3.7M
3VRTXVERTEX PHARMACEUTICALS INC4.72%8,429$3.6M
4AMGNAMGEN INC4.55%10,791$3.5M
5REGNREGENERON PHARMACEUTICALS3.90%4,227$3.0M
6ALNYALNYLAM PHARMACEUTICALS INC2.09%5,396$1.6M
7INSMINSMED INC1.60%8,773$1.2M
8RVMDREVOLUTION MEDICINES INC1.55%8,065$1.2M
9BIIBBIOGEN INC1.46%5,971$1.1M
10UTHRUNITED THERAPEUTICS CORP1.35%1,783$1.0M
11ARGXARGENX SE - ADR1.22%1,155$937K
12RPRXROYALTY PHARMA PLC- CL A1.14%17,436$875K
13ILMNILLUMINA INC1.13%6,224$867K
14ROIVROIVANT SCIENCES LTD1.08%29,134$826K
15INCYINCYTE CORP1.02%8,102$787K
Page 1 of 6

Detailed Returns

PeriodReturnETF
1D
+1.18%
1W
+3.93%
1M
+2.13%
3M
+3.62%
6M
+14.07%
YTD
+10.58%
1Y
+107.57%
3Y
+50.26%
5Y
+4.86%

Moving Averages

20-Day MA

$84.09

Above 20-Day MA
50-Day MA

$81.99

Above 50-Day MA
200-Day MA

$72.17

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$89.34

Current Price

$86.10

52-Week Low

$39.84

$39.84$89.34

Current Yield

0.75%

Annual Dividend

$0.6167

Frequency

4x/year

Last Ex-Date

Dec 24, 2025

Dividend History

Ex-DateAmountPay Date
Dec 24, 2025$0.1346Dec 31, 2025
Sep 24, 2025$0.1805Sep 30, 2025
Jun 25, 2025$0.1706Jul 1, 2025
Mar 26, 2025$0.1309Apr 1, 2025
Dec 23, 2024$0.3964Dec 31, 2024
Sep 25, 2024$0.1528Oct 2, 2024
Jun 26, 2024$0.2648Jul 3, 2024
Mar 20, 2024$0.0403Mar 27, 2024
Dec 20, 2023$0.0384Dec 28, 2023
Dec 22, 2022$0.0199Dec 30, 2022
Sep 21, 2010$0.0878Sep 28, 2010

Dividend Payments Over Time

Category Comparison

MetricBIBHealthcare(207 ETFs)Biotech(41 ETFs)
Fund Info
Expense Ratio1.19%0.60%0.83%
AUM$76.8M$1.23B$1.46B
Dividend Yield0.75%3.25%1.97%
Avg Volume13.9K362.5K739.7K
Holdings27417766
Performance
1-Month Return+0.94%+2.59%+2.08%
6-Month Return+22.39%+8.69%+9.81%
YTD Return+6.66%+3.85%+1.82%
1-Year Return+114.72%+31.19%+49.59%

Compare with Another ETF

Search for an ETF to compare with BIB:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.